{"entity":{"type":"insider","cik":"0001442786","url":"/insider/0001442786","json_url":"/insider/0001442786.json","name":"Chan Phillip P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":17,"first":"2012-09-05","last":"2026-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Chan Phillip P.","source":"filing","n_filings":17,"first_seen":"2012-09-05","last_seen":"2026-06-15"}],"transactions":[{"id":5769495,"accession":"0001104659-26-074164","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-074164","line_url":"/filing/0001104659-26-074164#line-2","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10333.0,"shares_display":"10,333","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":4443.19,"total_display":"4,443.19","total_whole":"4,443","shares_owned_after":1744432.0,"shares_owned_after_display":"1,744,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-15","scope":"insider"},{"id":5769493,"accession":"0001104659-26-074164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-074164","line_url":"/filing/0001104659-26-074164#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":251136.0,"shares_display":"251,136","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":100454.4,"total_display":"100,454.40","total_whole":"100,454","shares_owned_after":1734099.0,"shares_owned_after_display":"1,734,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-15","scope":"insider"},{"id":8430262,"accession":"0001104659-23-126421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-126421","line_url":"/filing/0001104659-23-126421#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75188.0,"shares_display":"75,188","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":100000.04,"total_display":"100,000.04","total_whole":"100,000","shares_owned_after":1068704.0,"shares_owned_after_display":"1,068,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-15","scope":"insider"},{"id":6746039,"accession":"0001104659-22-125893","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-125893","line_url":"/filing/0001104659-22-125893#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5859.0,"shares_display":"5,859","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":7382.34,"total_display":"7,382.34","total_whole":"7,382","shares_owned_after":897279.0,"shares_owned_after_display":"897,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-09","scope":"insider"},{"id":6127644,"accession":"0001104659-22-125503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-125503","line_url":"/filing/0001104659-22-125503#line-2","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9850.0,"shares_display":"9,850","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":12411.0,"total_display":"12,411.00","total_whole":"12,411","shares_owned_after":891420.0,"shares_owned_after_display":"891,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-08","scope":"insider"},{"id":6127643,"accession":"0001104659-22-125503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-125503","line_url":"/filing/0001104659-22-125503#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14291.0,"shares_display":"14,291","price_per_share":1.264,"price_display":"1.26","price_state":"stated","total_value":18063.824,"total_display":"18,063.82","total_whole":"18,064","shares_owned_after":881570.0,"shares_owned_after_display":"881,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2022-12-08","scope":"insider"},{"id":6814624,"accession":"0001104659-22-099104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-099104","line_url":"/filing/0001104659-22-099104#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":59500.0,"total_display":"59,500.00","total_whole":"59,500","shares_owned_after":867279.0,"shares_owned_after_display":"867,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-12","scope":"insider"},{"id":6461844,"accession":"0001104659-22-072979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-072979","line_url":"/filing/0001104659-22-072979#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2221.0,"shares_display":"2,221","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":4108.85,"total_display":"4,108.85","total_whole":"4,109","shares_owned_after":768351.0,"shares_owned_after_display":"768,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-21","scope":"insider"},{"id":6147277,"accession":"0001104659-22-070156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-070156","line_url":"/filing/0001104659-22-070156#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":2.174,"price_display":"2.17","price_state":"stated","total_value":34784.0,"total_display":"34,784.00","total_whole":"34,784","shares_owned_after":766130.0,"shares_owned_after_display":"766,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-10","scope":"insider"},{"id":6240211,"accession":"0001104659-22-000566","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-000566","line_url":"/filing/0001104659-22-000566#line-3","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5462.0,"shares_display":"5,462","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":22121.1,"total_display":"22,121.10","total_whole":"22,121","shares_owned_after":768443.0,"shares_owned_after_display":"768,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-30","filed_date":"2022-01-03","scope":"insider"},{"id":6240208,"accession":"0001104659-22-000566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-000566","line_url":"/filing/0001104659-22-000566","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9538.0,"shares_display":"9,538","price_per_share":4.049895156217237,"price_display":"4.05","price_state":"stated","total_value":38627.9,"total_display":"38,627.90","total_whole":"38,628","shares_owned_after":762981.0,"shares_owned_after_display":"762,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2022-01-03","scope":"insider","n_lines":2},{"id":5460306,"accession":"0001104659-21-148900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-148900","line_url":"/filing/0001104659-21-148900#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":26250.0,"total_display":"26,250.00","total_whole":"26,250","shares_owned_after":753443.0,"shares_owned_after_display":"753,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-13","scope":"insider"},{"id":7833988,"accession":"0001104659-19-070448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-070448","line_url":"/filing/0001104659-19-070448#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16500.0,"shares_display":"16,500","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":59400.0,"total_display":"59,400.00","total_whole":"59,400","shares_owned_after":657688.0,"shares_owned_after_display":"657,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-06","scope":"insider"},{"id":6462539,"accession":"0001144204-18-064025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-18-064025","line_url":"/filing/0001144204-18-064025#line-2","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24337.0,"shares_display":"24,337","price_per_share":9.3695,"price_display":"9.37","price_state":"stated","total_value":228025.5215,"total_display":"228,025.52","total_whole":"228,026","shares_owned_after":503281.0,"shares_owned_after_display":"503,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-11","scope":"insider"},{"id":6892489,"accession":"0001144204-18-048704","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-18-048704","line_url":"/filing/0001144204-18-048704#line-8","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2731.0,"shares_display":"2,731","price_per_share":14.11,"price_display":"14.11","price_state":"stated","total_value":38534.41,"total_display":"38,534.41","total_whole":"38,534","shares_owned_after":438281.0,"shares_owned_after_display":"438,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-07","filed_date":"2018-09-07","scope":"insider"},{"id":6892482,"accession":"0001144204-18-048704","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-18-048704","line_url":"/filing/0001144204-18-048704#line-6","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":42775.0,"total_display":"42,775.00","total_whole":"42,775","shares_owned_after":441012.0,"shares_owned_after_display":"441,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-06","filed_date":"2018-09-07","scope":"insider"},{"id":6892476,"accession":"0001144204-18-048704","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-18-048704","line_url":"/filing/0001144204-18-048704","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5787.0,"shares_display":"5,787","price_per_share":14.85,"price_display":"14.85","price_state":"stated","total_value":85936.95,"total_display":"85,936.95","total_whole":"85,937","shares_owned_after":443912.0,"shares_owned_after_display":"443,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-07","scope":"insider","n_lines":2},{"id":4287246,"accession":"0001144204-17-031785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-031785","line_url":"/filing/0001144204-17-031785#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3700.0,"shares_display":"3,700","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":14800.0,"total_display":"14,800.00","total_whole":"14,800","shares_owned_after":399907.0,"shares_owned_after_display":"399,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-08","filed_date":"2017-06-08","scope":"insider"},{"id":4190616,"accession":"0001144204-17-031283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-031283","line_url":"/filing/0001144204-17-031283#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6300.0,"shares_display":"6,300","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":25200.0,"total_display":"25,200.00","total_whole":"25,200","shares_owned_after":396207.0,"shares_owned_after_display":"396,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-06","scope":"insider"},{"id":2646489,"accession":"0001144204-16-139122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-139122","line_url":"/filing/0001144204-16-139122#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4600.0,"shares_display":"4,600","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":24840.0,"total_display":"24,840.00","total_whole":"24,840","shares_owned_after":448103.0,"shares_owned_after_display":"448,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-09","filed_date":"2016-12-13","scope":"insider"},{"id":2197119,"accession":"0001144204-16-121338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-121338","line_url":"/filing/0001144204-16-121338#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.89,"price_display":"4.89","price_state":"stated","total_value":24450.0,"total_display":"24,450.00","total_whole":"24,450","shares_owned_after":121648.0,"shares_owned_after_display":"121,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-24","filed_date":"2016-08-26","scope":"insider"},{"id":3229250,"accession":"0001144204-12-049608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-049608","line_url":"/filing/0001144204-12-049608#line-1","is_derivative":false,"issuer_cik":"0001175151","issuer_name":"Cytosorbents Corp","issuer_ticker":"CTSO","issuer_name_source":null,"issuer_url":"/issuer/0001175151","owner_cik":"0001442786","owner_name":"Chan Phillip P.","owner_display_name":"Chan Phillip P.","owner_url":"/insider/0001442786","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190000.0,"shares_display":"190,000","price_per_share":0.13,"price_display":"0.13","price_state":"stated","total_value":24700.0,"total_display":"24,700.00","total_whole":"24,700","shares_owned_after":190000.0,"shares_owned_after_display":"190,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-04","filed_date":"2012-09-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001175151","name":"Cytosorbents Corp","url":"/issuer/0001175151","role":"Director, Officer (Chief Executive Officer)","n_filings":17,"first_seen":"2012-09-05","last_seen":"2026-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001442786","retrieved_at":"2026-08-24T12:39:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}